Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer

BACKGROUND: KRAS mutations occur in approximately 25% of patients with non-small cell lung cancer (NSCLC). Despite the uniform presence of KRAS mutations, patients with KRAS-mutant NSCLC can have a heterogeneous clinical course. Since the pattern of co-occurring mutations may describe different biol...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Arbour, Kathryn C., Jordan, Emmett, Kim, Hyunjae Ryan, Dienstag, Jordan, Yu, Helena A., Sanchez-Vega, Francisco, Lito, Piro, Berger, Michael, Solit, David B., Hellmann, Matthew, Kris, Mark G., Rudin, Charles M., Ni, Ai, Arcila, Maria, Ladanyi, Marc, Riely, Gregory J.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5771996/
https://ncbi.nlm.nih.gov/pubmed/29089357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-1841
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars